Partnership program designed to support collaborations with academic investigators to accelerate innovative early-staVanderbilt University Medical Center and Bayer have a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.ge, disease-relevant research towards the clinic.
- Multi-project collaboration with Nephrology
- Research activities include target validation, assay development and lead optimization